DK32989A - Immunoglobulin-konjugater og fremgangsmaade til fremstilling deraf - Google Patents

Immunoglobulin-konjugater og fremgangsmaade til fremstilling deraf

Info

Publication number
DK32989A
DK32989A DK032989A DK32989A DK32989A DK 32989 A DK32989 A DK 32989A DK 032989 A DK032989 A DK 032989A DK 32989 A DK32989 A DK 32989A DK 32989 A DK32989 A DK 32989A
Authority
DK
Denmark
Prior art keywords
procedures
preparing
immunoglobulin conjugates
conjugates
immunoglobulin
Prior art date
Application number
DK032989A
Other languages
Danish (da)
English (en)
Other versions
DK32989D0 (da
Inventor
James Jacob Starling
Bennett Coleman Laguzza
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DK32989D0 publication Critical patent/DK32989D0/da
Publication of DK32989A publication Critical patent/DK32989A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/04Dimeric indole alkaloids, e.g. vincaleucoblastine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6805Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a vinca alkaloid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
DK032989A 1988-01-27 1989-01-26 Immunoglobulin-konjugater og fremgangsmaade til fremstilling deraf DK32989A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14882288A 1988-01-27 1988-01-27

Publications (2)

Publication Number Publication Date
DK32989D0 DK32989D0 (da) 1989-01-26
DK32989A true DK32989A (da) 1989-07-28

Family

ID=22527543

Family Applications (1)

Application Number Title Priority Date Filing Date
DK032989A DK32989A (da) 1988-01-27 1989-01-26 Immunoglobulin-konjugater og fremgangsmaade til fremstilling deraf

Country Status (11)

Country Link
EP (1) EP0326322A1 (pt)
JP (1) JPH02152996A (pt)
KR (1) KR890011896A (pt)
CN (1) CN1034543A (pt)
AU (1) AU2878989A (pt)
DK (1) DK32989A (pt)
HU (1) HU199783B (pt)
IE (1) IE890237L (pt)
IL (1) IL89043A0 (pt)
PT (1) PT89504A (pt)
ZA (1) ZA89524B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5006652A (en) * 1988-08-08 1991-04-09 Eli Lilly And Company Intermediates for antibody-vinca drug conjugates
US5094849A (en) * 1988-08-08 1992-03-10 Eli Lilly And Company Cytotoxic antibody conjugates of hydrazide derivatized vinca analogs via simple organic linkers
IL93986A0 (en) * 1989-04-04 1991-01-31 Lilly Co Eli Improvements in and relating to pharmaceutical formulations
ES2049656B1 (es) * 1992-10-08 1994-11-16 Lilly Co Eli Grupos de conjugados de farmacos con anticuerpos.
CA2227326A1 (en) * 1995-05-15 1996-11-21 Philip Dehazya Carbohydrate-mediated coupling of peptides to immunoglobulins
SE0302324D0 (sv) * 2003-08-28 2003-08-28 Astrazeneca Ab Novel compounds
CN102898523B (zh) * 2012-10-19 2014-06-25 上海师范大学 N-取代四氢吡啶连吲哚-单克隆抗体cd14结合物及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR79899B (pt) * 1983-03-30 1984-10-31 Lilly Industries Ltd
US4675400A (en) * 1985-06-17 1987-06-23 Eli Lilly And Company Bifunctional derivatives of 4-desacetyl indole-dihydroindole alkaloids
ZA873600B (en) * 1986-05-27 1988-12-28 Lilly Co Eli Immunoglobulin conjugates
FR2610198B1 (fr) * 1987-02-03 1990-06-15 Ire Celltarg Sa Conjugues d'hydrazide d'alcaloide de vinca lie a une immunoglobuline, procede de preparation et compositions pharmaceutiques en comprenant

Also Published As

Publication number Publication date
EP0326322A1 (en) 1989-08-02
KR890011896A (ko) 1989-08-23
IE890237L (en) 1989-07-27
HU199783B (en) 1990-03-28
JPH02152996A (ja) 1990-06-12
PT89504A (pt) 1989-10-04
HUT48909A (en) 1989-07-28
DK32989D0 (da) 1989-01-26
AU2878989A (en) 1989-07-27
ZA89524B (en) 1990-09-26
CN1034543A (zh) 1989-08-09
IL89043A0 (en) 1989-08-15

Similar Documents

Publication Publication Date Title
DK665187A (da) Immunoglobulin-konjugater og fremgangsmaade til fremstilling heraf
DK260687A (da) Immunoglobulin-konjugater og fremgangsmaade til fremstilling deraf
NO891866D0 (no) Kromanderivater og fremgangsmaate for fremstilling derav.
DK502389D0 (da) Pyridazinonderivater og fremgangsmaade til fremstilling deraf
DK134288D0 (da) Kemo-radio-immuno-konjugat og fremgangsmaade til fremstilling heraf
DK556689A (da) Antistof-konjugater, fremgangsmaade til fremstilling heraf og farmaceutiske midler indeholdende disse
DK159288D0 (da) Saccharidblanding og fremgangsmaade til fremstilling deraf
DK335986A (da) Poly-4-aminopropyl-2-carboxamidoderivat og fremgangsmaade til fremstilling deraf
DK69989D0 (da) Benzodioxolderivater og fremgangsmaade til fremstilling deraf
NO892494L (no) Kromanderivater og fremgangsmaate for fremstilling derav.
DK1693A (da) Pyranobenzoxadiazolderivat og fremgangsmaade til fremstilling deraf
NO894103L (no) Kromanderivater og fremgangsmaate for fremstilling derav.
DK202989D0 (da) Antitumormidler og fremgangsmaade til fremstilling deraf
DK564889D0 (da) Fastgoerelseselement og fremgangsmaade til fremstilling heraf
DK32989D0 (da) Immunoglobulin-konjugater og fremgangsmaade til fremstilling deraf
DK397788A (da) Polyarylalkan-oligomer-praeparater og fremgangsmaade til fremstilling deraf
DK103889D0 (da) Benzimidazooe1,2-caachinazoliner og fremgangsmaade til fremstilling heraf
NO900252L (no) Cefasporinderivater og fremgangsmaate for fremstilling derav.
DK487688D0 (da) Benzofuranderivater og fremgangsmaade til fremstilling deraf
DK129689D0 (da) Ifosfamid-mesna-lyofilisat og fremgangsmaade til fremstilling deraf
NO893963D0 (no) 3-aryloksymetyl-cefalosporinderivater og fremgangsmaate til fremstilling derav.
DK624588D0 (da) 4-demethoxy-anthracyclin-derivater og fremgangsmaade til fremstilling deraf
NO924152D0 (no) Alkaloider og fremgangsmaate for fremstilling derav
DK319188D0 (da) Glycerolacetalaminoacylat og fremgangsmaade til fremstilling deraf
DK335288D0 (da) Peptolidderivater og fremgangsmaade til fremstilling deraf

Legal Events

Date Code Title Description
ATS Application withdrawn